

Bridging molecular imaging and clinical oncology.
The NucMed Congress serves as the premier international forum where laboratory radiochemists and clinical oncologists unite to advance peer-reviewed radiopharmaceutical research.


Translational science in action.
We are dedicated to accelerating the transition of novel radiopharmaceuticals from bench to bedside. By providing continuing education credits and academic recognition, we foster rigorous peer-reviewed research that directly impacts patient outcomes.
Our focus spans precise dosimetry, targeted radionuclide therapies, and novel PET/CT imaging protocols designed to map and treat complex malignancies.
Ten years of pioneering milestones.
Established to unite isolated laboratory radiochemists with frontline clinical practitioners, the congress has grown into the definitive global platform for molecular imaging and targeted radionuclide therapy.
Led by global experts.
Our international committees ensure the highest academic standards and peer-reviewed integrity across all plenary sessions and workshops.
Abstract & Peer Review
Logistics & Program
Global Standards
Overseeing the selection of original radiopharmaceutical data and clinical oncology submissions.
Structuring the congress program, plenary sessions, and continuing medical education credits.
Aligning international dosimetry protocols and molecular imaging guidelines.

